Sugi Predict
/ Targets
/ VSIR
Top predicted compounds (top 20 by supporting neighbours, then confidence)
Clinical trials — most relevant to VSIR by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
|---|
| A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease |
PHASE4 | UNKNOWN |
| Understanding the Immune Response to Two Different Meningitis Vaccines |
PHASE4 | COMPLETED |
| A Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Naïve Participants With Primary Immunodeficiency |
PHASE4 | COMPLETED |
| V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency |
PHASE3 | RECRUITING |
| A Clinical Study of Intravenous Immunoglobulin |
PHASE3 | COMPLETED |
| ZyVac-TCV Bangladesh Study |
PHASE3 | NOT_YET_RECRUITING |
| Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency |
PHASE3 | COMPLETED |
| Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD) |
PHASE3 | COMPLETED |
| Pembrolizumab (MK-3475) in MM Patients With Residual Disease |
PHASE2 | COMPLETED |
| Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma |
PHASE2 | RECRUITING |
| Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study) |
PHASE1/PHASE2 | WITHDRAWN |
| Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 Mutation |
PHASE2 | UNKNOWN |
| Effects on Microcirculation of IgGAM in Severe Septic/Septic Shock Patients. |
PHASE2 | COMPLETED |
| Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency |
PHASE1/PHASE2 | COMPLETED |
| Llama Antibody, Rotavirus Diarrhoea, Children |
PHASE2 | COMPLETED |
| Dose Escalation Trial of CD40.HIVRI.Env Vaccine Combined or Not With a DNA-HIV-PT123 HIV-1 Vaccine in Healthy Volunteers |
PHASE1 | COMPLETED |
| Analysis of the Mechanisms of Protective Humoral Immunity in Response to the Pneumococcal Vaccine |
PHASE1 | COMPLETED |
| A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors |
PHASE1 | COMPLETED |
| 68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis |
EARLY_PHASE1 | UNKNOWN |
| Modulatory Effect of Prodigiosin or Pioglitazone on TIME and the Crosstalk to Immune-Checkpoint Protein(s) |
nan | NOT_YET_RECRUITING |
| VDJ-recombination of the B-cell Receptor Following Hematopoietic Stem Cell Transplantation |
nan | NOT_YET_RECRUITING |
| GLILD Diagnosed in Children and Young Adults With Common Variable Immunodeficiency |
nan | UNKNOWN |
| Impaired Secretory IgA and Mucosal Immunity in Cystic Fibrosis |
nan | UNKNOWN |
| Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern Benin |
nan | COMPLETED |
| Angiogenesis and Fibrosis in Aortic Stenosis |
nan | COMPLETED |
| High Definition Profiling of Ovarian Cancer Ascites |
nan | NOT_YET_RECRUITING |
| Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors |
nan | NOT_YET_RECRUITING |
| Role of Neutrophil Activation in Anaphylaxis to Neuro-Muscular Blocking Agents |
nan | COMPLETED |
| Non-invasive Tumor Immunoglobulin Gene Next Generation Sequencing (IgNGS) in Diffuse Large B Cell Lymphoma (DLBCL) |
nan | UNKNOWN |
| Immune Checkpoints in Predicting Response to Neoadjuvant Therapy in Rectal Cancer |
nan | COMPLETED |
Related proteins — ESM-2 sequence neighbours (a VSIR binder may also engage these)